AEON Biopharma Appoints BOTOX(R) Therapeutic Head as President and Chief Executive Officer

Dynamic Industry Veteran Led Multi-Billion Dollar Therapeutic Neurotoxin Portfolio NEWPORT BEACH, Calif., May 13, 2019 -- (Healthcare Sales & Marketing Network) -- ALPHAEON Corporation announced today that its Board of Directors has named Marc Forth as... Biopharmaceuticals, Personnel AEON Biopharma, ALPHAEON, botulinum toxin
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news